News About: Pharm. Industry
GSK reorganizes the company on a large scale, including reconstruction of its employeesThe Korean branch of GSK decided to make reorganization of the company on a large scale. In other words, it is creating strategies to adopt the current industrial environment, s...
|
Multinational pharmaceutical companies express “We are trying to make sale alliances, but there is no company to consign”
“It is hard to select a partner in the current circumstance where decent companies already have a number of partnership products.”
Marketers of multinational pharmaceutical companies, preparing launches of new drugs ...
The Nagoya Protocol increases burden on companies
As the Nagoya Protocol, sharing earnings for using foreign natural resources, is enforced, it is expected that domestic companies need to pay royalties worth of 1-3% of sales if a domestic law is ratified.
However, a...
A 4-day great journey will begin for the global pharmaceutical market
At the moment where pharmaceutical companies in Korea are accelerating expansion to the global market, the 5th Korea Pharm 2015 will be opened for 4 days from 21 April at the 1st conference room of KINTEX in Goyang.
...
The less profits pharmaceutical companies make, the more sales management expenses need to be spent
It is known that mid-sized pharmaceutical companies between KRW 100 billion and KRW 200 billion sales made soundest growth last year. They actualized profits proportional to sales growth. On the other hand, large phar...
The average annual wage of internal directors of listed pharmaceutical companies is KRW 245 million
It is known that internal directors of listed pharmaceutical companies received KRW 245 million annual wages in average last year.
According to the Medipana News’s ‘2014 Current State on Annual Wages of Internal Dire...
Patient associations argue “If Xalkori is introduced in the National Health Insurance Committee…”
The Pfizer’s non-small cell lung cancer treatment ‘Xalkori (generic name: crizotinib)’ has gotten closer to application of the National Health Insurance Service. It is expected that the benefit will be provided if the...
Dongwha Pharm strengthened its psychiatric treatment field via cooperation with Pfizer
Dongwha Pharm has shown its power in the psychiatric treatment market.
Dongwha Pharm held a convention with Pfizer on the last 2nd and agreed on working as its sales agency to distribute the Pfizer Korea’s 4 products...
The market capitalization of pharmaceutical stocks increased 1,786% up for the past 10 years
It is estimated that pharmaceutical stocks listed in KOSDAQ increased 1,786% up for the last 10 years.
In particular, pharmaceutical stocks listed in KOSDAQ achieved eye-opening growth compared to other industries sh...
Pharmaceutical companies spent the most in biotechnology as their R&D expenses
The section that spent the most expenses in research courses was observed to be the technological field for biotechnology.
The Korea Health Industry Development Institute unveiled the analysis result of research expe...
